Sign Up Today and Learn More About Codiak Biosciences Stock

Invest in or calculate the value of your shares in Codiak Biosciences or other pre-IPO companies through EquityZen's platform.

Get Started

Codiak Biosciences Stock


About Codiak Biosciences Stock




San Francisco, CA, US

Notable Investor

Fidelity Investments

Total Funding


Codiak Biosciences is developing exosomes, natural vesicles that mediate inter-cellular communication, as both a powerful therapeutic modality and an advanced diagnostic system. Codiak is building a world-class team and has generated and acquired foundational intellectual property that will allow it to capitalize on the unique potential of exosome biology.

Investors in Codiak Biosciences

Discover investors in Codiak Biosciences stock and explore their portfolio companies

Codiak Biosciences Management

Leadership team at Codiak Biosciences

Chief Executive Officer

Doug Williams

Chief Business Officer

Richard Brudnick

Locked Features

Join now and verify your accreditation status to gain access to:

  • Codiak Biosciences current valuation
  • Codiak Biosciences stock price
  • Available deals in Codiak Biosciences and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Codiak Biosciences stock?

Accredited investors can buy pre-IPO stock in companies like Codiak Biosciences through EquityZen funds. These investments are made available by existing Codiak Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Codiak Biosciences stock?

Shareholders can sell their Codiak Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."